Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Clinical trial NCT06445062 · RECRUITING

Trial details

NCT number: NCT06445062
Sponsor: Revolution Medicines, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer CRC Pancreatic Ductal Adenocarcinoma PDAC Gastrointestinal Cancer Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2024-05-24
Primary completion: 2027-05-15
Enrollment: 1130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.